PS Ratio
1.88
+0.02+1.08%
Sat, 22 Feb 2025 00:59:45 GMT
Summary
- As of February 24, 2025, HRTX price to sales ratio is 1.88, with a rise of +0.02 (+1.08%) during the most recent trading day.
- Over the past year, HRTX PS ratio has dropped by -1.33 (-41.43%).
- HRTX PS ratio is now -99.71% below its all-time high of 642.98.
Performance
HRTX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
HRTX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +1.1% | +1.2% | +1.2% | +1.0% |
| 1 m1 month | +5.0% | +4.9% | +4.9% | - |
| 3 m3 months | +56.7% | +56.0% | +56.0% | 0.0% |
| 6 m6 months | -13.0% | -12.4% | -12.2% | - |
| ytdytd | +11.2% | +11.1% | +11.1% | - |
| 1 y1 year | -41.4% | -37.3% | -36.5% | 0.0% |
| 5 y5 years | -85.8% | -92.1% | -86.7% | -5.6% |
HRTX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.4% | 1.79 | +5.0% | |
| 3 m | 3-month | 2.50 | -24.8% | 1.20 | +56.7% |
| 6 m | 6-month | 2.50 | -24.8% | 1.20 | +56.7% |
| 1 y | 1-year | 4.48 | -58.0% | 1.20 | +56.7% |
| 3 y | 3-year | 8.94 | -79.0% | 0.69 | +172.5% |
| 5 y | 5-year | 22.60 | -91.7% | 0.69 | +172.5% |
| alltime | all time | 642.98 | -99.7% | 0.69 | +172.5% |
Heron Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | 1.88(+11.2%) |
| 2024 | 1.69(-16.7%) |
| 2023 | 2.03(-26.7%) |
| 2022 | 2.77(-74.3%) |
| 2021 | 10.79(-50.5%) |
| 2020 | 21.81(+50.0%) |
| 2019 | 14.54(-44.4%) |
| 2018 | 26.17(-31.1%) |
| 2017 | 38.01(-90.6%) |
| 2016 | 403.09(+2802.0%) |
| 2010 | 13.89(-65.2%) |
| 2009 | 39.90(+13.6%) |
| 2008 | 35.12(-70.2%) |
| 2007 | 117.80(+1543.0%) |
| 2005 | 7.17(-6.2%) |
| 2004 | 7.64(-26.7%) |
| Date | Value |
|---|---|
| 2003 | 10.43(+123.3%) |
| 2002 | 4.67(-73.3%) |
| 2001 | 17.46(+22.4%) |
| 2000 | 14.26(+135.3%) |
| 1999 | 6.06(-54.9%) |
| 1998 | 13.43(+78.1%) |
| 1997 | 7.54(+1.2%) |
| 1996 | 7.45(+31.4%) |
| 1995 | 5.67(+28.6%) |
| 1994 | 4.41(+1.6%) |
| 1993 | 4.34(-70.9%) |
| 1992 | 14.90(-60.3%) |
| 1991 | 37.50(+329.6%) |
| 1990 | 8.73(-53.7%) |
| 1989 | 18.86(-15.4%) |
| 1988 | 22.29(-20.5%) |
| 1987 | 28.03 |
FAQ
- What is Heron Therapeutics price to sales ratio?
- What is the all time high PS ratio for Heron Therapeutics?
- What is HRTX price to sales ratio year-to-date change?
- What is Heron Therapeutics PS ratio year-on-year change?
What is Heron Therapeutics price to sales ratio?
The current PS ratio of HRTX is 1.88
What is the all time high PS ratio for Heron Therapeutics?
Heron Therapeutics all-time high price to sales ratio is 642.98
What is HRTX price to sales ratio year-to-date change?
Heron Therapeutics price to sales ratio has changed by +0.19 (+11.24%) since the beginning of the year
What is Heron Therapeutics PS ratio year-on-year change?
Over the past year, HRTX price to sales ratio has changed by -1.33 (-41.43%)